WITHDRAWN: Plasma GPI and PGD are associated with vascular normalization and may serve as novel prognostic biomarkers for lung adenocarcinoma: Multi-omics and multi-dimensional analysis

The authors have withdrawn their manuscript owing to adjustments have been made to the content. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was supported by the National Natural Science Foundation of China (82273715, 82203771), the National Key Research and Development Program of China (2022YFC2503202), the Science and Technology Program of Nantong City (MS22022062, JC22022002), the Talent Training Climbing Action Plan Project of the Sixth People's Hospital of Nantong, and the Postgraduate Research and Practice Innovation Program of Jiangsu Province (KYCX21-3126, KYCX20-2852). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The ethics committee of Nantong University gave ethical approval for this work (Approval No. 2022-2). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced in the present study are available upon reasonable request to the authors